Posted on

Female Genital Tract Tissue Arrays

Please send your request for detailed information and quote to: info@vitrovivo.com

SKU#

DESCRIPTION

CASE

CORE

PRICE ($)

UT1001 Endometrial cancer tissue array for antibody screening, including pathology grade, TNM and clinical stage, 25 cases/100 cores 25 100 331.50
UT501b Endometrioid carcinoma tissue array with normal tissue, including pathology grade, TNM and clinical stage, 50 cases/50 cores, replacing UT501a 50 50 253.50
T095 Endometrium cancer test tissue array (4x (2×3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores 6 24 45.50
T094-1 Endometrium cancer test tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12cases/ 24cores, replacing T092 12 24 71.50
EM1021b(EM1021a) Endometrium cancer with endometrium tissue array, including pathology grade, TNM and clinical stage, 102 cases/102 cores, replacing EM1021a 102 102 331.50
UT243 Endometrium cancer with matched cancer adjacent endometrium tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replaced by UT243a 12 24 71.50
UT243b Endometrium cancer with matched cancer adjacent endometrium tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replaced UT243a 12 24 71.50
UT240 Endometrium cancer, endometrium hyperplasia tissue array with adjacent tissue as control, including pathology grade, TNM and clinical stage, 24 cases/24 cores 24 24 84.50
UTN801a(UTN801) Endometrium tissue and endometrium cancer tissue array, including pathology grade, TNM and clinicla stage, 79 cases/80 cores, replacing UTN801 79 80 448.50
CR2083 Cervix cancer and adjacent normal survey tissue array (1 of 5), including pathology grade, TNM and clinical stage, 104 cases/208 cores 104 208 513.50
CR485 Cervix cancer and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores 48 48 331.50
CR2088 Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases/208 cores 208 208 591.50
CR2089 Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases/208 cores 208 208 591.50
CR2085 Cervix cancer survey tissue array, including pathology grade, TNM, clinical stage, 104 cases/208 cores 104 208 513.50
CC10-02-002 Cervix cancer tissue array with adjacent normal and cancer adjacent tissue, including pathology grade, TNM and clinical stage, 63 cases/63 cores 63 63 292.50
CR501b(CR501a) Cervix cancer tissue array with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 50 cases/50 cores, replacing CR501a 50 50 253.50
CR245 Cervix cancer tissue array with matched adjacent cervix tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores 12 24 84.50
T102a Cervix cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T102 12 24 71.50
T103a Cervix cancer with adjacent normal cervix tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T103 6 24 52.00
CER502 Cervix cancer with cervix tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 43 cases/50 cores 50 50 175.50
CR802b Cervix cancer with cervix tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 65 cases/80 cores, replacing CR802a 65 80 292.50
CR245b Cervix cancer with matched cancer adjacent cervix tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing CR245a 12 24 84.50
CR243a Cervix cancer with normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores, replacing CR243 24 48 182.00
CER501 Cervix squamous cell carcinoma with cervix tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores 50 50 175.50
CR2086 Cervix tumor tissue array (4 of 5), including pathology grade, TNM and clinical stage, 104 cases/208 cores 104 208 617.50
CR1921 Middle-advanced stage cervix cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores 96 192 513.50
CR1001a Multiple cervix cancer tissue array with cancer adjacent and adjacent normal tissue, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing CR1001 50 100 292.50
CR244a Uterine cervix cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing CR241 12 24 71.50
CR602b Uterine cervix disease spectrum tissue array, including pathology grade, TNM and clinical stage, 60 cases/60 cores, replacing CR602a 60 60 292.50
UT1501 Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores 75 150 279.50
UT803 Uterus cancer with endometrium tissue array, including pathology grade, TNM and clinical satge, 40 cases/80 cores 40 80 331.50
UT721 Uterus cancer with normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores 24 72 331.50
T103 Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases/24 cores, replaced by T103a 6 24 52.00
T104 Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores 6 24 52.00
CR246 Cervix adenocarcinoma with cervix tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage , 22 cases/24 cores 22 24 182.00
OV603a Ovarian serous cystadenoma tissue array with normal tissue as control, 30 cases/60 cores, replacing OV603 30 60 292.50
OV482 Multiple ovarian cancer tissue array with normal tissues, including pathology grade, 24 cases/48 cores 24 48 214.50
OV8010 Different stage of ovary cancer tissue array (1999 WHO classification) with metastasis carcinoma, including pathology diagnosis, TNM and clinical stage, 80 cases/80 cores 80 80 331.50
OV8010b Different stage of ovary cancer tissue array (1999 WHO classification) with metastasis carcinoma, including pathology diagnosis, TNM and clinical stage, 80 cases/80 cores 80 80 331.50
OV208a High density ovary cancer and ovary tissue array (1999 WHO classification), with metastatic adenocarcinoma, including pathology grade, TNM and clinical stage, 69 cases/207 cores, replacing OV208 69 207 591.50
OV2001a High-density ovary cancer with adjacent normal ovary tissue array (1999 WHO classification), with metastatic carcinoma, including pathology grade, TNM and clinical stage, 200 cases/200 cores, replacing OV2001 200 200 448.50
OV806 Normal ovary tissue array, 30 cases/60 cores 30 60 292.50
CR242 Ovary cancer array with adjacent normal tissue, including pathology grade, 12 cases/24 cores 12 24 71.50
OV20810 Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases/208 cores 208 208 591.50
OV20811 Ovary cancer tissue array (2 of 4), including TNM and pathology grade, 208 cases/208 cores 208 208 591.50
OV20812 Ovary cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases/208 cores 208 208 591.50
OV20813 Ovary cancer tissue array (4 of 4), including TNM and pathology grade, 208 cases/208 cores 208 208 591.50
OV701 Ovary cancer tissue array and adjacent normal ovary tissue, including TNM, clinical stage and pathology grade, 70 cases/70 cores, replacing BC111110 70 70 240.50
OV702a Ovary cancer tissue array with adjacent normal tissue as control, including TNM and pathology grade, 70 cases/70 cores,replacing BC111109 70 70 279.50
OV243 Ovary cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 2 serial sections, 24 cases/48 cores 24 48 292.50
OV481 Ovary cancer tissue array with unmatched adjacent normal tissue, including pathology grade, 24 cases/48 cores 24 48 214.50
OV484 Ovary cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores 48 48 292.50
OV803c Ovary cancer tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing OV803b 80 80 331.50
T114 Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores 6 24 52.00
OV803b Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replaced by OV803 80 80 331.50
OVR502 Ovary cancer with adjacent normal ovary tissue array (2014 WHO classification), including TNM and clinical satge (AJCC 7th edition), 50 cases/50 cores 50 50 175.50
T111b Ovary cancer with adjacent normal ovary tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T111a 6 24 71.50
OV801a Ovary cancer with adjacent normal ovary tissue array, including pathology grade, TNM and clinical stage, 77 cases/80 cores, replacing OV801 77 80 292.50
OV242a Ovary cancer with adjacent normal ovary tissue array, including TNM and pathology grade, 12 cases/24 cores, replacing OV242 12 24 71.50
OV811 Ovary cancer with normal tissue array (1999 WHO classification), including pathology grade, TNM and clinical stage, 40 cases/80 cores 40 80 331.50
OV807a Ovary cancer with ovary tissue array (2014 WHO classification), including patology grade, TNM and clinical stage (AJCC 7th edition), 40 cases/80 cores 40 80 292.50
OVR501 Ovary cancer with ovary tissue array (2014 WHO classification), including TNM and clinical satge (AJCC 7th edition), 50 cases/50 cores 50 50 175.50
OV241c Ovary cancer with ovary tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing OV241b 12 24 71.50
OV809a Ovary cancer with ovary tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV809 80 80 331.50
FOV-807a Ovary cancer with ovary tissue array, including patology grade (2014 WHO classification), TNM and clinical stage (AJCC 7th edition), 40 cases/80 cores, replacing OV807 40 80 292.50
OV483b Ovary cancer with ovary tissue array, including TNM and clinical stage, 48 cases/48 cores, replacing OV483a 48 48 214.50
T112c Ovary cancer with overy tissue array, including pathology grade, TNM and clinical stage, 12 cases/ 24 cores, replacing T112b 12 24 52.00
OV1005c Ovary disease spectrum (ovary cancer progression) tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing OV1005b 100 100 292.50
OV1005d Ovary disease spectrum (ovary cancer progression) tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing OV1005c 100 100 292.50
OV602 Ovary granulosa-theca cell tumor (malignant and benign) and cysts tissue array, 60 cases/60 cores 60 60 292.50
OV804 Ovary krukenberg tumor tissue array, 80 cases/80 cores 80 80 279.50
OV805 Ovary teratoma tissue array, 80 cases/80 cores 80 80 292.50
OV2086 Ovary tumor survey tissue array (2 of 5), including pathology grade, TNM and clinical stage, 104 cases/208 cores 104 208 513.50
OV1002 Ovary tumor tissue array, 100 cases/100 cores 100 100 331.50
OV485 Ovary tumor tissue array, including pathology grade, TNM and clinical stage, 2 serial sections, 48 cases/96 cores 48 96 448.50
OV961 Ovary tumor tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores 48 96 240.50
OV962 Ovary tumor tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores 48 96 240.50
OV1501a Ovary tumor tissue array, including TNM and pathology grade, 75 cases/150 cores, replacing OV1501 75 150 292.50
OV808b Peritoneum and omentum secondary tumor tissue array (all from ovary), including pathology grade, 40 cases/80 cores, replacing OV808a 40 80 331.50
OV2084a Ovary carcinoma tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 208 cases/208 cores, replacing OV2084 208 208 591.50
T471 Uterine tube tumor with uterine tube tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores 6 24 71.50
UT801b(UT801a) External genitalia malignant tumor tissue array, including TNM, clinical stage and pathology grade, 39 cases/78 cores 80 80 448.50
UV801 External genitalia malignant tumor tissue array, including TNM, clinical stage and pathology grade, 39 cases/78 cores 39 78 279.50
VUL501 Vulva tumor and normal tissue array, including pathology grade, TNM and clinical stage, 50 cases/50 cores 50 50 221.00
BE01017 Different gestational age of fetal multiple organ normal tissue array, 10 cases/72 cores 10 72 292.50
BE01018 Fetal multiple organ normal tissue array, 14 cases/54 cores 14 54 214.50
BE01016 Fetal multiple organ normal tissue array, 4 cases/78 cores 4 78 214.50

TMA Applications:

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH)

Notes:

1) TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.

TNM Grading

T – Primary tumor
      Tx – Primary tumor cannot be assessed
      T0 – No evidence of primary tumor
      Tis – Carcinoma in situ; intraepithelial or invasion of lamina propria
      T1 – Tumor invades submucosa
      T2 – Tumor invades muscularis propria
      T3 – Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
      T4 – Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N – Regional lymph nodes
     Nx – Regional lymph nodes cannot be assessed
     N0 – No regional lymph node metastasis
     N1 – Metastasis in 1 to 3 regional lymph nodes
     N2 – Metastasis in 4 or more regional lymph nodes

M – Distant metastasis
     Mx – Distant metastasis cannot be assessed
     M0 – No distant metastasis
     M1 – Distant metastasis

Stage of Cancer

  • Stage 0 means there’s no cancer, only abnormal cells with the potential to become cancer. This is also called carcinoma in situ.
  • Stage I means the cancer is small and only in one area. This is also called early-stage cancer.
  • Stage II and III mean the cancer is larger and has grown into nearby tissues or lymph nodes.
  • Stage IV means the cancer has spread to other parts of your body. It’s also called advanced or metastatic cancer.